Generic drug sales growth in US to slow down?

May 01, 2019, 06:25 AM

The US pharmaceutical market has gone through a structural change. Analysts expect growth of this sector in the US to moderate at around 2 or 3 percent per year as against 8 to 9 percent seen earlier. In this episode, Ekta Batra discusses the pharmaceutical market with Chirag Talati, associate director, Kotak Securities.  #TheMedicineBox on aims to give you an insight into all things pharma and health – from discussing trends in the industry to key issues in health with all the relevant experts. The third series of #TheMedicineBox focuses on pharmaceutical space. In this series, Batra talks to the top sell-side analysts covering the pharma and healthcare sector. They share their views on the big emerging trends, the big growth markets, R&D, and more.